Post-Bariatric Hypoglycemia (PBH): Diagnostic and Therapeutic Strategies

Size: px
Start display at page:

Download "Post-Bariatric Hypoglycemia (PBH): Diagnostic and Therapeutic Strategies"

Transcription

1 Post-Bariatric Hypoglycemia (PBH): Diagnostic and Therapeutic Strategies Mary-Elizabeth Patti MD Investigator and Adult Endocrinologist Research Division Director, Hypoglycemia Clinic Joslin Diabetes Center Associate Professor of Medicine Harvard Medical School

2 DISCLOSURES Collaborative R44 NIH grant: Xeris Pharmaceuticals, Harvard Engineering Supply support: Dexcom, Insulet Investigator-initiated research grant: Medimmune, Janssen Previous site investigator: Xoma Multicenter ARMMS clinical trial: Funding support: NIH U01 Consultant: Eiger Pharmaceuticals

3 Joslin Christopher Mulla Allison Goldfine CRC Nurses & Staff Kathy Foster Lauren Richardson Pam Walcott Patients! Emmy Suhl RD Nicole Patience RD Joanne Rizzotto RD Jonathan Dreyfuss Hui Pan Ping Li Ali Bajwa Ipsa Arora Rohit Kulkarni Susan Bonner-Weir Gordon Weir Franco Folli Stefano La Rosa Thank you to Harvard School of Engineering Eyal Dassau Alejandro Laguna Stamatina Zavitsanou Sunil Deshpande Frank Doyle BIDMC Radiology Elisa Franquet Gerald Kolodny George Watts Surgery David Lautz Jim Moser Other Colleagues Marzieh Salehi UT San Antonio Adrian Vella Mayo Clinic Tracey McLaughlin Stanford University Jens Holst University of Copenhagen Funding NIDDK-SBIR (with Xeris) Dexcom Insulet NIH U01 ARMMS

4 Hypoglycemia is Increasingly Recognized After Bariatric Surgery Normal Anatomy Roux-en-Y Gastric Bypass (RYGB) Vertical Sleeve Gastrectomy (VSG) Fundoplication and Other Upper Gastrointestinal Surgery

5 Post-Bariatric Hypoglycemia (PBH) Hypoglycemia is increasingly recognized in patients following bariatric surgery gastric bypass > sleeve gastrectomy Mild postprandial hypoglycemia can be considered a component of the postprandial dumping syndrome Mild cases responsive to dietary management to limit simple CHO

6 Severe Post-Bariatric Hypoglycemia (PBH) A subset of patients have severe hypoglycemia: Requiring assistance of others Neuroglycopenia: seizures, falls, loss of consciousness, motor vehicle accidents Often hypoglycemia unawareness Job/income loss, cognitive dysfunction, loss of driving, disability Characterized by rapid spike in glucose after meals, excessive GLP1 and insulin secretion, later postprandial hypoglycemia Often require both medical nutrition therapy & multiple medications to achieve safety Therapy focused to reduce glycemic excursions

7 OVERVIEW Clinical presentation of post-bypass hypoglycemia syndrome Diagnostic strategies How can we differentiate whether symptoms are due to hypoglycemia or other conditions in post-bariatric patients? How can we define the underlying cause of hypoglycemia? Current concepts of pathophysiology Practical management strategies

8 Representative Patient History 66 year old female with obesity since adolescence (BMI 48 kg/m2) No personal or family history of DM or hypoglycemia Laparascopic Roux-en-Y gastric bypass without complications Symptoms of dumping syndrome immediately postoperatively, resolved with dietary modification Presented at 24 months postop (BMI 35 kg/m 2, stable) with palpitations, sweating, and confusion Could this be hypoglycemia?

9 Hypoglycemia Symptoms Adrenergic Tremor Palpitations Anxiety Cholinergic Sweating Hunger Paresthesias Neuroglycopenia Impaired cognition Seizures Consciousness These symptoms are often nonspecific! Overlap with dumping syndrome occurring after meals in bariatric patients Consider also: anxiety, cardiovascular disease, orthostatic hypotension

10 Hypoglycemia Symptoms Adrenergic Tremor Palpitations Anxiety Cholinergic Sweating Hunger Paresthesias Neuroglycopenia Impaired cognition Seizures Consciousness Hypoglycemia Unawareness: A Threat to Safety loss of adrenergic or cholinergic warning symptoms abrupt onset of neuroglycopenia can result in serious falls, motor vehicle accidents, seizures, loss of consciousness

11 What is Required to Define Hypoglycemia? A. Low capillary glucose at time of symptoms B. Low plasma glucose at time of symptoms C. Relief of symptoms by raising glucose D. A and C E. B and C Answer: E Defines Whipple s triad Why is plasma glucose required? cold exposure, vasospasm, meter error Allen O. Whipple surgeon

12 Patient History (continued) Presented to clinic for initial appointment Complained about feeling fatigued, slightly confused Venous glucose 34 mg/dl (1.9 mm) Responded within 15 minutes to 15 g CHO Fulfilled Whipple s triad We were lucky! Hypoglycemia confirmed

13 Diagnostic Strategies

14 Clinical Evaluation of Possible PBH History of Episodes Symptoms? Onset? Type of surgery? Weight trajectory? Severity? Neuroglycopenia? Assistance required? Relation to fasting, meals Provocative foods? Nocturnal symptoms? Coexisting medical issues? Meds? Record-keeping can be helpful Food & symptom log Blinded CGM to identify patterns CGM not for diagnosis as less accurate in hypoglycemia range Typical Patterns in PBH More than 1 year after GI surgery 1-3 hours after eating More common after simple CHO Worse with liquids>solids Not when fasting Occasionally: during/after exercise during overnight hours (2-4 AM)

15 The Roller Coaster of Post-Bypass Glycemia Postprandial spikes 70 Some nocturnal lows Postprandial lows Range: ; 15% of readings under 70 (0-25%)

16 Glycemic Patterns in Post-Bariatric Hypoglycemia

17 Glycemic Patterns in Post-Bariatric Hypoglycemia: Response to Mixed Meal during Research Studies Rapid spike after eating Normal fasting glucose Glucose (mg/dl) * * Time (min) Rapid drop after peak Goldfine & Patti, JCEM 2007

18 Which of the following are not typical patterns in PBH? A. Hypoglycemia before breakfast B. Hypoglycemia beginning 6 months after gastric bypass C. Hypoglycemia 2 hours after last meal D. A, B E. All of the above Answer: D If fasting hypoglycemia or shortly after surgery, not typical of PBH consider alterative diagnoses!

19 What other diagnoses shoud we be considering? Insulinoma 22% present with postprandial hypo Inadequate nutrition/weight loss Adrenal insufficiency Autoimmune hypoglycemia Other systemic disease (liver, kidney) Medication effects Alcohol use Comprehensive history, exam, & targeted labs needed!

20 Patient History (continued) Symptoms occur 5 times per week Symptoms typically occur within 1-2 hours after eating More likely to occur after eating simple CHO No symptoms upon awakening in AM Has been using husband s glucometer Most of readings at time of symptoms are mg/dl Occasionally has autonomic symptoms when glucose >200

21 No prior hypoglycemia Weight stable No relevant medications Patient History (continued) No family history of MEN1 components or hypo No alcohol Exam: BMI 34, otherwise normal Fasting labs: glucose 82 mg/dl, cortisol 12 ug/dl, hemoglobin A1c 5.3%

22 What are the Next Best Step(s) in her Evaluation? A. Oral glucose tolerance test B. 72 hour inpatient fasting test C. Mixed meal tolerance test D. Food, symptom, and glucose log E. Venous sample at time of hypoglycemia, if not already obtained Answers: C, D, E

23 Can We Provoke Hypoglycemia? How? Oral glucose tolerance test? Not well-tolerated in post-gi surgery patients Can provoke severe dumping 10% of healthy have glucose <50 mg/dl during GTT, without neuroglycopenia or EEG changes Hypoglycemia during OGTT physiological hypoglycemia! Hogan et al Mayo Clin Proc 1983

24 Can We Provoke Hypoglycemia? How? What about mixed meal tolerance test? Protein, carbohydrate, and fat No standard at present Liquid vs. solid Varying CHO content: g Be prepared! possible severe hypoglycemia requiring assistance Ensure safe testing environment, ability to rescue

25 What is appropriate glucose threshold to define hypoglycemia? NOT symptoms alone nonspecific, can reflect dumping in this population Strict definition best: Plasma glucose <54 mg/dl* (3 mm) at time of neuroglycopenic symptoms Symptoms promptly relieved with oral CHO *Diabetes Care 2017 ADA/EASD recommendations for hypoglycemia definition

26 What about measuring insulin levels? Insulin responses quantified in clinical studies of PBH during prolonged fast: insulin suppressed (<3 uu/ml) Challenges with post-meal hypoglycemia: Rapid increases in insulin levels after meals At time of subsequent hypoglycemia, insulin not suppressed (e.g. >3 uu/ml, or the lower limit of assay) Secretion Clearance time Plasma Insulin

27 When should we do prolonged inpatient fast? A. All patients with PBH with typical symptoms B. Patients who have fasting hypoglycemia C. Patients who have hypoglycemia early after surgery (<6-12 months) D. Never! E. B and C E. We reserve inpatient fasting to rule out insulinoma for those with atypical symptom patterns fasting, early postop, or unresponsive to therapy.

28 Should we do imaging to exclude insulinoma? Rarely Fasting hypoglycemia & nonsuppressed insulin Other atypical clinical features Lack of response to therapy Imaging for insulinoma notoriously challenging Consider CT, MRI, endoscopic ultrasound Very rare need for arteriogram or selective arterial calcium stimulation testing

29 Symptoms Adrenergic, Cholinergic, or Neuroglycopenic Possible Hypoglycemia Glucose Level During Symptoms? <70 mg/dl >70 mg/dl Can hypoglycemia be confirmed at the time of symptoms? Hypoglycemic Sx + neuroglycopenia Documented glc <50 (venous glucose preferred, spontaneous or provoked*) Relief with CHO YES Hypoglycemic Disorder Assess Patterns & Severity,?Neuroglycopenia R/O Other Causes of Hypoglycemia** NO Unlikely Hypoglycemia Consider Dumping Syndrome, CV Disorders Postprandial pattern? >6 mo after surgery? Likely Post-Bariatric Hypoglycemia Syndrome Initial Treatment Nutrition, Acarbose Salehi Patti JCEM 2018 Fasting or nocturnal hypoglycemia? Started < 6 mo after bariatric surgery? Incomplete Response Frequent Neuroglycopenia Atypical symptoms for post-bariatric hypoglycemia! Consider other hypoglycemic disorders Reassess Patterns With Diary/Masked CGM, Consider Further Hormonal Testing***, Additional Meds****

30 OVERVIEW Clinical presentation of post-bypass hypoglycemia syndrome Diagnostic strategies How can we differentiate whether symptoms are due to hypoglycemia or other conditions in post-bariatric patients? How can we define the underlying cause of hypoglycemia? Current concepts of pathophysiology Practical management strategies

31 Altered Glucose Patterns after Mixed Meal in PBH Spike after eating Nonsurgical Normal fasting glucose Nadir Salehi 2014

32 Altered Postprandial Metabolism after Mixed Meal in PBH Spike after eating Insulin Levels Glc Absorption Insulin Secretion GLP-1 Levels Nadir Salehi 2014

33 Roux-en-Y Gastric Bypass (RYGB) Rapid delivery of nutrients to foregut Early & high peak of glucose Postprandial secretion of GLP1 (10x) GLP1R inh Insulin secretion in postprandial state suppression of insulin secretion with hypoglycemia clearance of insulin Other hormones Insulin-independent glucose uptake Neural effects Postprandial Hypoglycemia

34 Role of Altered Counterregulation?

35 Reduced Counterregulatory Responses during Hypoglycemic Clamp after RYGB Glucagon pre post- RYGB Cortisol post- RYGB Epinephrine Norepinephrine post- RYGB post- RYGB Abrahamsson et al Diabetes 2016

36 What About the Pancreas in Severe PBH? Anti-Glucagon Stain CONTROL Patient 1 Patient 2 Patient 3 Partial pancreatectomy for refractory hypoglycemia Not performed any longer as not curative No insulinoma Diffuse increase in islet number Islets of varying size & shape Patti et al Diabetologia, 2005; Service NEJM 2005

37 RYGB: Patients requiring pancreatectomy for severe hypoglycemia (n=6) Controls: Organ donors or benign tumors (n=10) Reubi & Patti, Diabetologia 2010; increased size/number not consistently observed (Butler et al) Islet Size in Some Series of Patients with Severe PBH Anti- Insulin Staining Control Post-RYGB Insulinoma Islet Size (mm2) PBH CON * Islet number per mm2 PBH CON

38 β-cell Mass is Not a Dominant Contributor! PBH is a Functional Disorder, not Anatomic! Acute feeding via G tube into bypassed stomach largely resolves excessive GLP1 and insulin secretion and hypoglycemia Acute inhibition of GLP1 signaling improves hypoglycemia Partial pancreatectomy does not cure hypoglycemia!

39 Both Insulin-Dependent and Independent Mechanisms Contribute to Hypoglycemia Intestinal hormones Bile acids Altered intestinal mucosa Intestinal glucose uptake Altered gut-liver-brain axis Altered counterregulation

40 OVERVIEW Clinical presentation of post-bypass hypoglycemia syndrome Diagnostic strategies How can we differentiate whether symptoms are due to hypoglycemia or other conditions in post-bariatric patients? How can we define the underlying cause of hypoglycemia? Current concepts of pathophysiology Practical management strategies

41 Goals of Therapy Reduce frequency and severity Improve safety Unlikely complete elimination of hypoglycemia

42 Safety: Test glucose before driving, before bed, and in situations where hypoglycemia likely: After meals, after exercise Nocturnal, especially if AM headaches, vivid dreams, sweating Consider diagnostic or personal CGMS to detect trends early and treat before becomes severe, especially in those with unawareness. Family instruction in glucagon use It is effective as therapy! Medical ID Clinical Management Strategies Correct nutrient deficiencies: B12, D, B-complex, Fe, Ca, minerals Cornstarch (grocery, Extend, UCAN) Glucagon Kit

43 All of the following are important options for initial treatment of PBH except A. Eliminate all carbohydrates B. Controlled consumption of low glycemic index carbohydrates C. Acarbose D. Instruction in use of glucagon for family E. Instruction in treating acute hypoglycemia with simple carbohydrates Answer: A. Complete elimination of all carbs may contribute to reduced nutritional status, risk of hypoglycemia during sleep/activity, reduced responsiveness to glucagon.

44 Medical Nutrition Therapy is the Cornerstone of Treatment of PBH Prevention: reduce stimulus for insulin secretion Avoid intake of simple carbohydrates (high GI) Controlled portions of complex carbs (low GI)» Starting point: 30 g/meal, vary by response Not total CHO elimination reduce glycogen stores, reduce responsiveness to glucagon Standard Diet Controlled CHO Diet Reduced glycemic excursions Nielsen 2016

45 10-Point Nutrition Plan for PBH Dietary measures alone are often not sufficient in severely affected patients but remain the cornerstone of therapy! Suhl et al. SOARD 2017

46 Choose Low Glycemic Index CHO (GOOD!) Avoid High Glycemic Index CHO Suhl et al. SOARD 2017

47 Stepped Pharmacology for PBH Acarbose: Disaccharidase inhibitor Aim: slow CHO absorption postprandial glucose spike stimulus for insulin secretion Often limited by abdominal gas Start gradually, increase to maximum 300 mg/day Can be administered only or in higher doses before meal usually producing hypoglycemia May have improved efficacy if taken 15 minutes before eating

48 Effects of Acarbose : Peak Glucose, Nadir Glucose, Insulin Peak, GLP1 Glucose Insulin GLP1 Valderas Obesity Surgery 2012

49 Stepped Pharmacology for PBH Acarbose Octreotide or pasireotide to incretin & insulin secretion options: preprandial SQ and monthly IM 50 μg pre-meal to start Often limited by diarrhea Occasional worsening of hypoglycemia immediately after injection, possibly due to inhibition of glucagon secretion

50 Somatostatin Analogues? Octreotide or pasireotide? Myint 2012 Eur J Endo SSTR1, 2, 3, 5 with pasireotide LJM de Heide SOARD 2017

51 Stepped Pharmacology for PBH Acarbose Octreotide or pasireotide to incretin & insulin secretion options: preprandial SQ and monthly IM 50 μg pre-meal to start Often limited by diarrhea; gallstones Occasional worsening of hypoglycemia immediately after injection, possibly due to inhibition of glucagon secretion Diazoxide to reduce insulin secretion, limited by edema Other - small response to calcium channel blockade, anticholinergics, metformin, GLP1 agonists, glucocorticoids in my experience Consider if severe: G tube feeds into remnant stomach. Reversal of bypass when feasible. NOT pancreatectomy - not curative, not a mass problem

52 G-Tube Delivery of Nutrients into the Bypassed Stomach in PBH Patient Yields Normal Insulin Secretion Oral G-tube Oral G G tube data O G GLP1 Plasma Glucose O GIP O Insulin G O G G Glucagon McLaughlin T JCEM 2010

53 G-Tube Delivery of Nutrients into the Bypassed Stomach in Severe PBH Patients Can Be Therapeutic Oral G-tube Options for chronic Rx: Bolus Overnight Continuous Different formulas & rates Avoid CHO by mouth CHO via G-tube tolerated Limited by quality of life issues McLaughlin T JCEM 2010

54 Not Pancreatectomy! - Symptom Recurrence is Nearly Universal after Partial Pancreatectomy Symptom- Free Survival Median time to recurrence of hypoglycemia 16 mo 64% were post-bariatric No difference in subsets of bariatric, +SACST, pathology Vanderveen et al. Surgery 2010

55 Consider Reversal of Bariatric Surgery for Severe PBH Davis et al, 2018; Arora et al, 2018

56 SUMMARY OF THERAPEUTIC APPROACHES Monitoring Hypo Safety/Education Medical Therapy Dietary Modification Surgical Therapy JCEM review 2018 Salehi Patti 2018

57 Thank You!

Hypoglycemia After Bariatric Surgery: Diagnostic and Therapeutic Strategies

Hypoglycemia After Bariatric Surgery: Diagnostic and Therapeutic Strategies Hypoglycemia After Bariatric Surgery: Diagnostic and Therapeutic Strategies Mary-Elizabeth Patti MD Investigator and Adult Endocrinologist Research Division Director, Hypoglycemia Clinic Joslin Diabetes

More information

Developing a Treatment for Post-Bariatric Hypoglycemia. December 9, 2016

Developing a Treatment for Post-Bariatric Hypoglycemia. December 9, 2016 Developing a Treatment for Post-Bariatric Hypoglycemia December 9, 2016 Forward-Looking Statements This presentation and the oral commentary contain forward-looking statements that involve substantial

More information

Subcutaneous exendin (9-39) effectively treats post-bariatric hypoglycemia

Subcutaneous exendin (9-39) effectively treats post-bariatric hypoglycemia Subcutaneous exendin (9-39) effectively treats post-bariatric hypoglycemia C OLLEEN M. CRAIG, M.D. T RACEY L. MC L AUGHLIN, M.D., M.S. Division of Endocrinology, Metabolism & Gerontology Stanford University

More information

Endocrine topic reviews. Artit Sangkakam, MD 19, september 2013

Endocrine topic reviews. Artit Sangkakam, MD 19, september 2013 Endocrine topic reviews Artit Sangkakam, MD 19, september 2013 Hypoglycemia in Non-DM Definition In diabetic mellitus : Plasma glucose 70 mg/dl In Non-diabetic mellitus : Plasma glucose 55 mg/dl Normal

More information

Hypoglycemia in congenital hyperinsulinism

Hypoglycemia in congenital hyperinsulinism How a normal body works: Our body is constantly at work. Our cells need a source of energy, and this source of energy is called glucose. The process is quite simple; think of it like an assembly line.

More information

Drs Maaz Sohail, FAU Resident and Bryan Vinik, Endocrinology

Drs Maaz Sohail, FAU Resident and Bryan Vinik, Endocrinology Drs Maaz Sohail, FAU Resident and Bryan Vinik, Endocrinology HPI: 75M referred for hypoglycemia with symptoms that started 18 months ago. Patient states that after drinking wine at night he would up confused

More information

Appetite, Glycemia and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant and Duodenal Administration of a Mixed Meal Test After

Appetite, Glycemia and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant and Duodenal Administration of a Mixed Meal Test After Appetite, Glycemia and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant and Duodenal Administration of a Mixed Meal Test After Roux-en-Y Gastric Bypass June 2018 How a surgical complication

More information

Hypoglycaemic disorders

Hypoglycaemic disorders Hypoglycaemic disorders 1. Hypoglycaemia in patients with diabetes mellitus 2. Hypoglycaemia in non-diabetic patients 3. Clinical, laboratory and imaging diagnosis 4. Case report 5. GLP-1 receptor scintigraphy

More information

David Bruyette, DVM, DACVIM Medical Director

David Bruyette, DVM, DACVIM Medical Director VCAWLAspecialty.com David Bruyette, DVM, DACVIM Medical Director The pancreas is made up of endocrine and exocrine tissue. The endocrine pancreas is composed of islets of Langerhans, which make up approximately

More information

Chief of Endocrinology East Orange General Hospital

Chief of Endocrinology East Orange General Hospital Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage

More information

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,

More information

Managing Endocrine Related Issues after Bariatric Surgery. Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018

Managing Endocrine Related Issues after Bariatric Surgery. Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018 Managing Endocrine Related Issues after Bariatric Surgery Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018 Bariatric Surgery was Associated with Higher Remission Rate than Usual Care 72.3% 38.1%

More information

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), in which blood glucose predominantly originates from

More information

Viriato Fiallo, MD Ursula McMillian, MD

Viriato Fiallo, MD Ursula McMillian, MD Viriato Fiallo, MD Ursula McMillian, MD Objectives Define obesity and effects on society and healthcare Define bariatric surgery Discuss recent medical management versus surgery research Evaluate different

More information

Introduction SHORT COMMUNICATION

Introduction SHORT COMMUNICATION Diabetologia (2005) 48: 2236 2240 DOI 10.1007/s00125-005-1933-x SHORT COMMUNICATION M. E. Patti. G. McMahon. E. C. Mun. A. Bitton. J. J. Holst. J. Goldsmith. D. W. Hanto. M. Callery. R. Arky. V. Nose.

More information

SHORT COMMUNICATION. J. C. Reubi & A. Perren & R. Rehmann & B. Waser & E. Christ & M. Callery & A. B. Goldfine & M. E. Patti

SHORT COMMUNICATION. J. C. Reubi & A. Perren & R. Rehmann & B. Waser & E. Christ & M. Callery & A. B. Goldfine & M. E. Patti Diabetologia (2010) 53:2641 2645 DOI 10.1007/s00125-010-1901-y SHORT COMMUNICATION Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic

More information

Pancreas Fox Chapter 18 part 2 (also Chapter 19.3 & 19.4)

Pancreas Fox Chapter 18 part 2 (also Chapter 19.3 & 19.4) Vert Phys PCB3743 Pancreas Fox Chapter 18 part 2 (also Chapter 19.3 & 19.4) T. Houpt, Ph.D. Anatomy of Digestive System Peristalsis Stomach and Acid Secretion Liver and Bile Secretion Pancreas and pancreatic

More information

Bariatric surgery results in sustained weight loss and

Bariatric surgery results in sustained weight loss and DIABETES TECHNOLOGY & THERAPEUTICS Volume 20, Number 2, 2018 ª Mary Ann Liebert, Inc. DOI: 10.1089/dia.2017.0298 ORIGINAL ARTICLE Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm

More information

University of Groningen. Dumping syndrome after esophageal, gastric or bariatric surgery van Beek, A.P.; Emous, M.; Laville, Maurice; Tack, Johannes

University of Groningen. Dumping syndrome after esophageal, gastric or bariatric surgery van Beek, A.P.; Emous, M.; Laville, Maurice; Tack, Johannes University of Groningen Dumping syndrome after esophageal, gastric or bariatric surgery van Beek, A.P.; Emous, M.; Laville, Maurice; Tack, Johannes Published in: Obesity Reviews DOI: 10.1111/obr.12467

More information

Technique. Matthew Bettendorf, MD Essentia Health Duluth Clinic. Laparoscopic approach One 12mm port, Four 5mm ports

Technique. Matthew Bettendorf, MD Essentia Health Duluth Clinic. Laparoscopic approach One 12mm port, Four 5mm ports Matthew Bettendorf, MD Essentia Health Duluth Clinic Technique Laparoscopic approach One 12mm port, Four 5mm ports Single staple line with no anastamosis 85% gastrectomy Goal to remove

More information

Goals & Objectives. Diabetes Mellitus

Goals & Objectives. Diabetes Mellitus Rudy R. Navarro, M.D., CAQSM Department of Family & Community Medicine UT Health Science Center at San Antonio Goals & Objectives Understand the patterns of glucose utilization during exercise and sporting

More information

Treating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric

Treating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric Treating Type 2 Diabetes with Bariatric Surgery Number (in Millions) of Persons with Diagnosed Diabetes, United States, 198 25 The number of Americans with diabetes increased from 5.6 to 15.8 million Guilherme

More information

Overview. o Limitations o Normal regulation of blood glucose o Definition o Symptoms o Clinical forms o Pathophysiology o Treatment.

Overview. o Limitations o Normal regulation of blood glucose o Definition o Symptoms o Clinical forms o Pathophysiology o Treatment. Pål R. Njølstad MD PhD KG Jebsen Center for Diabetes Research University of Bergen, Norway Depertment of Pediatrics Haukeland University Hospital Broad Institute of Harvard & MIT Cambridge, MA, USA Hypoglycemia

More information

4/23/2015. Linda Steinkrauss, MSN, PNP. No conflicts of interest

4/23/2015. Linda Steinkrauss, MSN, PNP. No conflicts of interest Linda Steinkrauss, MSN, PNP No conflicts of interest 1 5 year old African-American female presented to our Endocrinology Clinic with hypoglycemia Abnormal chromosomes Duplication of 11q13.5-11p14.1 affecting

More information

Postgastrectomy Syndromes

Postgastrectomy Syndromes Postgastrectomy Syndromes Postgastrectomy syndromes are iatrogenic conditions that may arise from partial gastrectomies, independent of whether the gastric surgery was initially performed for peptic ulcer

More information

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Results of the STAMPEDE Trial Philip R Schauer, Deepak L Bhatt, John P Kirwan, Kathy Wolski, Stacy A Brethauer,

More information

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully.

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully. Hypoglycemia Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized early, hypoglycemia

More information

hypoglycemia after gastric bypass surgery An emerging complication

hypoglycemia after gastric bypass surgery An emerging complication REVIEW EDUCATIONAL OBJECTIVE: Readers will be alert to the possible complication of hypoglycemia in patients who have undergone bariatric surgery RICHARD MILLSTEIN, DO Division of Endocrinology, Metabolism,

More information

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient Bariatric Surgery Policy Number: Original Effective Date: MM.06.003 09/11/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient;

More information

First-in-Class Treatment for Hyperinsulinemic Hypoglycemia. January 31, 2017

First-in-Class Treatment for Hyperinsulinemic Hypoglycemia. January 31, 2017 358 First-in-Class Treatment for Hyperinsulinemic Hypoglycemia January 31, 2017 Forward-Looking Statement Certain statements contained herein including, but not limited to, expected licensing transactions,

More information

BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS

BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS George Vl Valsamakis European Scope Fellow Obesity Visiting iti Associate Prof Warwick Medical School Diabetes is an increasing healthcare epidemic throughout

More information

A54-year-old nurse with a long-standing history of. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies

A54-year-old nurse with a long-standing history of. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies MINI-REVIEW Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies Marzieh Salehi, 1 * Adrian Vella, 2 * Tracey McLaughlin, 3 * and Mary-Elizabeth Patti 4 * 1 Diabetes Division,

More information

OBESITY AND WEIGHT LOSS SURGERY FOR THE PRIMARY CARE PHYSICIAN

OBESITY AND WEIGHT LOSS SURGERY FOR THE PRIMARY CARE PHYSICIAN OBESITY AND WEIGHT LOSS SURGERY FOR THE PRIMARY CARE PHYSICIAN Nicole Basa, M.D., F.A.C.S., F.A.S.M.B.S Assistant Professor of Surgery Texas A&M Medical School Bariatric Medical Director- Cedar Park Regional

More information

CME Post Test. D. Treatment with insulin E. Age older than 55 years

CME Post Test. D. Treatment with insulin E. Age older than 55 years CME Post Test Translational Endocrinology & Metabolism: Metabolic Surgery Update Please select the best answer to each question on the online answer sheet. Go to http://www.endojournals.org/translational/

More information

Obesity and Weight Loss Surgery for the Primary Care Physician

Obesity and Weight Loss Surgery for the Primary Care Physician Saturday General Session Obesity and Weight Loss Surgery for the Primary Care Physician Nicole Basa, MD Bariatric and General Surgeon Cedar Park Surgeons, PA Cedar Park, Texas Educational Objectives By

More information

What is Metabolic About Metabolic Surgery? The New ADA Recommendations

What is Metabolic About Metabolic Surgery? The New ADA Recommendations What is Metabolic About Metabolic Surgery? The New ADA Recommendations Obesity Symposium September 16, 2017 Timothy Howland, MD Lourdes Endocrinology Bariatric from the Greek root bar- ("weight" as in

More information

Diabetes: Inpatient Glucose control

Diabetes: Inpatient Glucose control Diabetes: Inpatient Glucose control Leanne Current, PharmD, BCPS This activity is funded through the Medicaid section 1115(a) Demonstration Texas Healthcare Transformation and Quality Improvement Program

More information

Subject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119

Subject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119 Acarbose, diabetes prevention trials 32, 33, 40 42 Accelerator hypothesis accelerators beta cell autoimmunity 140, 141, 147, 150, 151 insulin resistance 140, 142 144, 150 obesity 145 148 diabetes risk

More information

9/11/2012. Chapter 11. Learning Objectives. Learning Objectives. Endocrine Emergencies. Differentiate type 1 and type 2 diabetes

9/11/2012. Chapter 11. Learning Objectives. Learning Objectives. Endocrine Emergencies. Differentiate type 1 and type 2 diabetes Chapter 11 Endocrine Emergencies Learning Objectives Differentiate type 1 and type 2 diabetes Explain roles of glucagon, glycogen, and glucose in hypoglycemia Learning Objectives Discuss following medications

More information

Hypoglyceamia and Exercise

Hypoglyceamia and Exercise Hypoglyceamia and Exercise Noreen Barker Diabetes Specialist Nurse May 2016 Hypoglyceamia What is a hypo? Why are we concerned? Signs and symptoms Treatments Causes Hypo unawareness Managing diabetes and

More information

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m. Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, 2018 10:15 a.m. 11:00 a.m. Type 2 diabetes mellitus (T2DM) is closely associated with obesity, primarily through the link

More information

7/28/17. Objectives: Hypoglycemia Unawareness in the Geriatric Patient: A Safety Concern. Disclaimer:

7/28/17. Objectives: Hypoglycemia Unawareness in the Geriatric Patient: A Safety Concern. Disclaimer: Hypoglycemia Unawareness in the Geriatric Patient: A Safety Concern 29TH ANNUAL TNP CONFERENCE TRANSFORMING HEALTHCARE IN TEXAS SEPTEMBER 8, 2017 AUSTIN, TEXAS Kenneth Lowrance, DNP, APRN, CNS, FNP-BC,

More information

Scope. History. History. Incretins. Incretin-based Therapy and DPP-4 Inhibitors

Scope. History. History. Incretins. Incretin-based Therapy and DPP-4 Inhibitors Plasma Glucose (mg/dl) Plasma Insulin (pmol/l) Incretin-based Therapy and Inhibitors Scope Mechanism of action ผศ.ดร.นพ.ว ระเดช พ ศประเสร ฐ สาขาว ชาโภชนว ทยาคล น ก ภาคว ชาอาย รศาสตร คณะแพทยศาสตร มหาว ทยาล

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle

6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle Bariatric Surgery: What the Primary Care Provider Should Know 2,000 B.C. 2,000 A.D. Case Presentation: Rachelle 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression obstructive

More information

Type 2 diabetes and metabolic surgery:

Type 2 diabetes and metabolic surgery: Type 2 diabetes and metabolic surgery: Shouldn't we call it again again bariatric? Josep Vidal Obesity Unit. Endocrinology and Nutrition Department Hospital Clínic, University of Barcelona (Spain) What

More information

Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes

Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes The Harvard community has made this article openly available. Please share how this access

More information

National Position Statement

National Position Statement National Position Statement Weight Loss Surgery (Bariatric Surgery) and its Use in Treating Obesity or Treating and Preventing Diabetes Background Approximately twenty five per cent (25%) of Australian

More information

Management of Type 2 Diabetes

Management of Type 2 Diabetes Management of Type 2 Diabetes Pathophysiology Insulin resistance and relative insulin deficiency/ defective secretion Not immune mediated No evidence of β cell destruction Increased risk with age, obesity

More information

10/28/11. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle

10/28/11. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle Bariatric Surgery: What the Primary Care Provider Should Know 2,000 B.C. 2,000 A.D. Case Presentation: Rachelle 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression obstructive

More information

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of

More information

Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function

Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function Background. Following meal ingestion, several hormones are released from the gastrointestinal tract. Some

More information

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT

More information

LEARNING OBJECTIVES. Obesity. Obesity. Consequences of Malnutrition in Obesity: Undernutrition Concurrent with Overnutriton. Obesity.

LEARNING OBJECTIVES. Obesity. Obesity. Consequences of Malnutrition in Obesity: Undernutrition Concurrent with Overnutriton. Obesity. @PhD_Leigh #BariatricSurgery #Nutrition LEARNING OBJECTIVES Consequences of Malnutrition in : Undernutrition Concurrent with Overnutriton Leigh A. Frame, PhD, MHS Program Director in Integrative Medicine,

More information

Diabetic Gastroparesis. Evan M. Klass, MD, FACP February 16, 2017

Diabetic Gastroparesis. Evan M. Klass, MD, FACP February 16, 2017 Diabetic Gastroparesis Evan M. Klass, MD, FACP February 16, 2017 Scope of the problem The disorder can affect any part of the GI tract Although 10-20% of the general population suffer from functional GI

More information

HHS Public Access Author manuscript Obesity (Silver Spring). Author manuscript; available in PMC 2016 May 01.

HHS Public Access Author manuscript Obesity (Silver Spring). Author manuscript; available in PMC 2016 May 01. Prevalence of Hypoglycemic Symptoms after Roux-en-Y Gastric Bypass and Vertical Sleeve Gastrectomy and Associated Risk Factors Clare J. Lee 1, Jeanne M. Clark 2, Michael Schweitzer 3, Thomas Magnuson 3,

More information

Metabolic Syndrome: What s so big about BIG?

Metabolic Syndrome: What s so big about BIG? Tuesday, 10:00 11:30, A2 Objectives: Notes: Metabolic Syndrome: What s so big about BIG? Patrice Conrad pbconrad1@att.net 1. Identify advances in clinical assessment and management of selected healthcare

More information

Non-insulin treatment in Type 1 DM Sang Yong Kim

Non-insulin treatment in Type 1 DM Sang Yong Kim Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay

More information

Rebecca Newberry APRN MS CDE

Rebecca Newberry APRN MS CDE Current Diabetes Medications Nursing Implications and Applications Rebecca Newberry APRN MS CDE Methodist Center for Diabetes and Nutritional Health Disclosures Objectives Speakers Bureaus/Consulting Board

More information

Benefits of Bariatric Surgery

Benefits of Bariatric Surgery Benefits of Bariatric Surgery Dr Tan Bo Chuan Registrar, Department of Surgery GP Forum 27 May 2017 Improvements of Co-morbidities Type 2 diabetes mellitus Hypertension Hyperlipidemia Degenerative joint

More information

High and Low GH: an update of diagnosis and management of GH disorders

High and Low GH: an update of diagnosis and management of GH disorders High and Low GH: an update of diagnosis and management of GH disorders Georgia Chapter-AACE 2017 Laurence Katznelson, MD Professor of Medicine and Neurosurgery Associate Dean of Graduate Medical Education

More information

Hypoglycemia, Sick Days/DKA and Hospitalization

Hypoglycemia, Sick Days/DKA and Hospitalization Hypoglycemia, Sick Days/DKA and Hospitalization General survival skills for your client with diabetes at home and in Hospital Diabetes Canada guidelines for your client with diabetes while they are in

More information

Inpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy

Inpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy Inpatient Management of Diabetes Mellitus Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy 2 Disclosure Jessica Garza does not have any actual or potential conflicts of

More information

Diabetes Review. October 31, Dr. Don Eby Tracy Gaunt Dwayne Cottel

Diabetes Review. October 31, Dr. Don Eby Tracy Gaunt Dwayne Cottel Diabetes Review October 31, 2012 Dr. Don Eby Tracy Gaunt Dwayne Cottel Diabetes Review Learning Objectives: Describe the anatomy and physiology of the pancreas Describe the effects of hormones on the maintenance

More information

Managing Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide)

Managing Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide) Managing Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide) INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of

More information

Here are some types of gastric bypass surgery:

Here are some types of gastric bypass surgery: Gastric Bypass- Definition By Mayo Clinic staff Weight-loss (bariatric) surgeries change your digestive system, often limiting the amount of food you can eat. These surgeries help you lose weight and can

More information

I. General Considerations

I. General Considerations 1 2 3 I. General Considerations A. Type I ( Juvenile Onset or IDDM) IDDM results from autoimmune destruction of beta cells inability to secrete insulin --> ketone formation --> DKA 4 Diabetic Ketoacidosis

More information

Week 3, Lecture 5a. Pathophysiology of Diabetes. Simin Liu, MD, ScD

Week 3, Lecture 5a. Pathophysiology of Diabetes. Simin Liu, MD, ScD Week 3, Lecture 5a Pathophysiology of Diabetes Simin Liu, MD, ScD General Model of Peptide Hormone Action Hormone Plasma Membrane Activated Nucleus Cellular Trafficking Enzymes Inhibited Receptor Effector

More information

Policy Specific Section: April 14, 1970 June 28, 2013

Policy Specific Section: April 14, 1970 June 28, 2013 Medical Policy Bariatric Surgery Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date: April 14, 1970 June 28, 2013 Definitions

More information

Diabetes in Chronic Pancreatitis: When is it type 3c? Melena Bellin, MD Associate Professor, Pediatrics & Surgery Schulze Diabetes Institute

Diabetes in Chronic Pancreatitis: When is it type 3c? Melena Bellin, MD Associate Professor, Pediatrics & Surgery Schulze Diabetes Institute Diabetes in Chronic Pancreatitis: When is it type 3c? Melena Bellin, MD Associate Professor, Pediatrics & Surgery Schulze Diabetes Institute Disclosure Information Melena D. Bellin Disclosure of Relevant

More information

Gastric Emptying Time after Laparoscopic Sleeve Gastrectomy

Gastric Emptying Time after Laparoscopic Sleeve Gastrectomy International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Original Research Article Volume 4, Issue 7-2018 Gastric Emptying Time

More information

Managing Acromegaly: Review of Two Cases

Managing Acromegaly: Review of Two Cases Managing Acromegaly: Review of Two Cases INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of patients with acromegaly who have

More information

Standards of Medical Care in Diabetes 2016

Standards of Medical Care in Diabetes 2016 Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking

More information

Use of Lanreotide (long acting Somatostatin analogue) in Congenital Hyperinsulinism (CHI)

Use of Lanreotide (long acting Somatostatin analogue) in Congenital Hyperinsulinism (CHI) Use of Lanreotide (long acting Somatostatin analogue) in Congenital Hyperinsulinism (CHI) Dr Pratik Shah Clinical Research fellow in Hyperinsulinism Clinical Molecular Genetics Unit Institute of Child

More information

Current Status of Bariatric Surgery in Asia

Current Status of Bariatric Surgery in Asia Emerald hall A, 1:2-1:5, November 7, 213 Current Status of Bariatric Surgery in Asia Go Wakabayashi, MD, PhD, FACS Professor and Chairman Department of Surgery Iwate Medical University Numbers of bariatric

More information

Obesity Management in Type 2 Diabetes

Obesity Management in Type 2 Diabetes Obesity Management in Type 2 Diabetes Clare J. Lee, MD, MHS Assistant Professor of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University Disclosures None Objectives Describe

More information

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with

More information

An Introduction to Bariatric Surgery

An Introduction to Bariatric Surgery An Introduction to Bariatric Surgery What is bariatric surgery? Bariatric surgery is a treatment used to help people with obesity manage their health and weight. Why use surgery to manage obesity? Obesity

More information

Endocrinology and VHL: The adrenal and the pancreas

Endocrinology and VHL: The adrenal and the pancreas Overview Endocrinology and VHL: The adrenal and the pancreas LAUREN FISHBEIN MD, PHD UNIVERSITY OF COLORADO SCHOOL OF MEDICINE DIVISION OF ENDOCRINOLOGY, METABOLISM AND DIABETES DIVISION OF BIOMEDICAL

More information

Commonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital

Commonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital Commonly Performed Bariatric Procedures in Singapore Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital Scope 1. Introduction 2. Principles of bariatric surgery

More information

Management of Pancreatic Islet Cell Tumors

Management of Pancreatic Islet Cell Tumors Management of Pancreatic Islet Cell Tumors Ravi Dhanisetty, MD November 5, 2009 Morbidity and Mortality Conference Case Presentation 42 yr female with chronic abdominal pain. PMHx: Uterine fibroids Medications:

More information

Gut involvement in PoTS an overview

Gut involvement in PoTS an overview Gut involvement in PoTS an overview Qasim Aziz, PhD, FRCP Centre for Neuroscience and Trauma Wingate Institute of Neurogastroenterology Case Hx * 28 year old lady presents with a long hx of constipation

More information

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM Type 2 DM in Adolescents: Use of GLP-1 RA Objectives Identify patients in the pediatric population with T2DM that would potentially benefit from the use of GLP-1 RA Discuss changes in glycemic outcomes

More information

Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς

Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς Αναστασία Θανοπούλου Επίκουρη Καθηγήτρια Β Παθολογικής Κλινικής Πανεπιστημίου Αθηνών Διαβητολογικό Κέντρο, Ιπποκράτειο Νοσοκομείο

More information

Understanding the Effects of Roux-en-Y Gastric Bypass (RYGB) Surgery on Type 2 Diabetes Mellitus

Understanding the Effects of Roux-en-Y Gastric Bypass (RYGB) Surgery on Type 2 Diabetes Mellitus Chapter 19 Understanding the Effects of Roux-en-Y Gastric Bypass (RYGB) Surgery on Type 2 Diabetes Mellitus Raymond G. Lau, Michael Radin, Collin E. Brathwaite and Louis Ragolia Additional information

More information

Gut and Brain Connection: A New Look. By William L Wilson, M.D.

Gut and Brain Connection: A New Look. By William L Wilson, M.D. Gut and Brain Connection: A New Look By William L Wilson, M.D. Central Nervous System Conscious and unconscious mental processing Monitor internal & external environments Auto-regulatory functions Regulates

More information

Dedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden

Dedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden Managing Diabetes in the Athletic Population Dedicated To Aiden Michael Prybicien, LA, ATC, CSCS, CES, PES Athletic Trainer, Passaic High School Overlook Medical Center & Adjunct Faculty, William Paterson

More information

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet

More information

Gastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor

Gastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor Gastrointestinal Surgery for Severe Obesity 2.0 Contact Hours Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2007 The Magellan Group, LLC All Rights Reserved. Reproduction and distribution

More information

ADVANCE Endpoints. Primary outcome. Secondary outcomes

ADVANCE Endpoints. Primary outcome. Secondary outcomes ADVANCE Trial-NEJM 11,140 type 2 patients with h/o microvascular or macrovascular disease or 1 vascular disease risk factor Control A1c to 6.5% vs standard tx Intensive arm received gliclazide XL 30 to

More information

Living Well with Diabetes

Living Well with Diabetes Living Well with Diabetes What is diabetes? Diabetes Overview Diabetes is a disorder of the way the body uses food for growth and energy. Most of the food people eat is broken down into glucose, the form

More information

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D Diabetes Oral Agents Pharmacology University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 Learning Objectives Understand the role of the utilization of free

More information

Goals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management

Goals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management The Current State of Surgical Intervention in Management of Morbid Obesity Goals Obesity over the last decade Surgery has become a safer management strategy Surgical options for management 1 Goals Obesity

More information

What is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming

What is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming The Bionic Pancreas Is Coming Montana Diabetes Professional Conference October 23, 2014 H. Peter Chase, MD Professor of Pediatrics University of Colorado Barbara Davis Center Stanford: Bruce Buckingham,

More information

Case Report Laparoscopic Adjustable Gastric Banding and Hypoglycemia

Case Report Laparoscopic Adjustable Gastric Banding and Hypoglycemia Case Reports in Endocrinology Volume 2013, Article ID 671848, 4 pages http://dx.doi.org/10.1155/2013/671848 Case Report Laparoscopic Adjustable Gastric Banding and Hypoglycemia Sigrid Bairdain, 1 Mark

More information

Common Diabetes-related Terms

Common Diabetes-related Terms Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes

More information

Adrenal Hormone Mineralocorticoids Aldosterone

Adrenal Hormone Mineralocorticoids Aldosterone Adrenal gland Adrenal Hormone Mineralocorticoids Aldosterone Cortex 80 % Glucocorticoids Cortisol Sex hormones Androgen Medulla 20% Catecholamines E, NE 1 2 Adrenal cortex hormones Glucocorticoid Mineralocorticoids

More information

Pancreatitis. Acute Pancreatitis

Pancreatitis. Acute Pancreatitis Pancreatitis Pancreatitis is an inflammation of the pancreas. The pancreas is a large gland behind the stomach and close to the duodenum. The duodenum is the upper part of the small intestine. The pancreas

More information

Effect of Bariatric Surgery on Cardio-Metabolic Outcomes

Effect of Bariatric Surgery on Cardio-Metabolic Outcomes Effect of Bariatric Surgery on Cardio-Metabolic Outcomes Disclosure Research support from Bariatric Advantage (supplements donated for research study) Anne Schafer, MD Associate Professor of Medicine and

More information

GLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks

GLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks GLP-1 Receptor Agonists and SGLT-2 Inhibitors Debbie Hicks Prescribing and Adverse Event reporting information is available at this meeting from the AstraZeneca representative The views expressed by the

More information